Presentation CCVVC 2016 Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials Presenter: Tyrone Collins June 15, 2016
Presentation CCVVC 2016 The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions Presenter: Chris Metzger June 15, 2016
Presentation CICT 2015 Drug Eluting Femoral Stents Where does it fit in my practice? Presenter: Yazan Khatib July 31, 2015
Presentation CCVVC 2015 Covered Stents in Femoropopliteal Disease Presenter: Subhash Banerjee June 18, 2015
Presentation Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions Presenter: Michael D. Dake April 10, 2013
Presentation Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents Presenter: T. Zeller April 03, 2013
Presentation TCT 2013 Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis Presenter: Alexandre Benjo, Francisco Macedo, Emad Aziz, Francisco Nascimento, Fahad Javed, Eyal Herzog, Tyrone Collins, Christopher White January 31, 2013
Presentation TCT 2012 A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions Presenter: Thomas Zeller October 24, 2012